MARY WAUGH: Open Payments
NPI 1134855281 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,948 in 93 payments from 13 companies in 2025. Trend: 2023 $920 · 2024 $1,775 · 2025 $1,948
Food & beverage: $1,948
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 8 | $496 |
| PFIZER INC. | 29 | $286 |
| Novartis Pharmaceuticals Corporation | 20 | $281 |
| EMD Serono, Inc. | 3 | $265 |
| ABBVIE INC. | 22 | $246 |
| Alexion Pharmaceuticals, Inc. | 1 | $97 |
| Biogen, Inc. | 3 | $88 |
| Lundbeck LLC | 2 | $51 |
| JAZZ PHARMACEUTICALS INC. | 1 | $38 |
| Eisai Inc. | 1 | $30 |
Products named: UPLIZNA, NURTEC ODT, KESIMPTA, Mavenclad, QULIPTA, UBRELVY, ULTOMIRIS, TYSABRI.
Industry payments across NY — which companies pay providers there.
